Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

CoreWeaves Q3 earnings beat and raised full-year outlook drew attention, with traders pointing to strong revenue growth and a large backlog as evidence of AI-compute demand. The reaction was divided: some welcomed the results, while others focused on heavy debt, rising interest costs, capital spending and potential dilution, helping explain the muted, fading post-earnings pop.

Capricors pending FDA decision on deramiocel is driving attention, with traders parsing an upbeat Q3 call and managements comments on review progress and launch readiness as possible signs of approval, though no decision is confirmed. The community remains sharply divided on the binary regulatory outcome, while the delayed NS Pharma arbitration and the post-call selloff add to concerns.

Netlists quarterly results and earnings call are driving attention, with traders highlighting a sharp profitability and margin improvement alongside revenue recognized under its Samsung licensing deal and a stronger cash position. Reactions are broadly optimistic about recurring licensing income and Micron payments expected to begin in a later quarter, but some question the decline in product sales and want clarity on SK hynix and forward guidance.

Nvidia is under pressure amid a board investigation into CEO Jensen Huangs relationship with an executive alleged to have ties to Chinese intelligence, and concerns that the scrutiny could raise export-control or leadership risks. Traders are split between viewing the selloff as an overreaction and buying opportunity, and fearing further losses if the probe leads to damaging findings or Huangs departure.

Rigettis quarterly results missed revenue expectations and its outlook disappointed, prompting selling and renewed scrutiny of its high valuation, limited commercial revenue and cash burn. Some investors remain bullish on its quantum-technology progress and government support, but the debate centers on whether technical advances can translate into meaningful business demand.

Amprius Q3 results are driving attention: revenue beat expectations and the company raised its full-year outlook, but an EPS miss and negative EBITDA coincided with a sharp selloff. Traders disagree over whether the decline is an overreaction to a narrow earnings miss or reflects concerns about profitability and cash burn.

Fireflys Q3 results, which traders characterize as a beat with a stronger outlook and growing backlog, are driving discussion, but many are frustrated by the muted share-price reaction. Bulls point to growth and contracts; skeptics focus on cash burn, negative EBITDA, and execution risks.

Traders are positioning around Infleqtions upcoming results, looking for updates on revenue guidance, contracts, backlog and quantum-computing milestones. The debate is whether execution and its commercial products can distinguish INFQ from other quantum stocks, while the shares remain volatile alongside the sector and broader tech market.

CoreWeaves earnings beat and raised outlook are being treated as a read-through for Nebius and the neocloud sector, with traders looking to Nebiuss upcoming results for confirmation of AI-compute demand. The community is divided between optimism about demand and growth and concerns that heavy capital spending, financing needs, and debt could undermine returns.

LightPaths fiscal first-quarter results are driving attention, with traders highlighting revenue growth, a larger backlog and strong order activity. Reactions are mixed: some view the results as evidence of improving momentum, while others are concerned that the performance may not be enough to support the growth expectations and are waiting for managements outlook.